Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Water for Injection (WFI) Quality Testing Method – V 2.0

Posted on By

Analytical Method Development: SOP for Water for Injection (WFI) Quality Testing Method – V 2.0

Standard Operating Procedure for Water for Injection (WFI) Quality Testing Method in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/272/2025
Supersedes SOP/AMD/272/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define a validated and comprehensive procedure for quality testing of Water for Injection (WFI) used in sterile pharmaceutical production, covering physicochemical parameters,

microbial contamination, and organic impurities in accordance with USP, Ph. Eur., and IP standards.

2. Scope

This SOP is applicable to the Analytical Method Development and Quality Control departments for routine and validation testing of WFI in pharmaceutical manufacturing facilities.

3. Responsibilities

  • Analytical Chemist: Performs physical, chemical, and TOC analysis of WFI samples.
  • Microbiologist: Conducts microbial limit tests and endotoxin testing.
  • QA Executive: Verifies and approves WFI testing reports and ensures compliance with pharmacopeial specifications.
See also  Analytical Method Development: SOP for Identification of Cream Base Components via FTIR - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring validated testing methods for WFI are implemented, and all testing conforms to current GMP and pharmacopeial guidelines.

5. Procedure

5.1 Sampling

  1. Collect WFI samples aseptically in sterile, pyrogen-free containers.
  2. Label all containers with sample location, date, and time of collection.
  3. Test immediately or within validated holding time (typically ≤ 4 hours).

5.2 Physicochemical Testing

  1. Appearance: Clear, colorless liquid.
  2. Conductivity: NMT 1.3 µS/cm at 25°C.
  3. pH: Between 5.0 and 7.0 (as per pharmacopeial method).
  4. Total Organic Carbon (TOC): NMT 500 ppb (µg/L), tested using TOC analyzer.
  5. Nitrate and Heavy Metals: Should be absent or below detection limits as per specifications.

5.3 Microbiological Testing

  1. Total Viable Aerobic Count: NMT 10 CFU/100 mL using membrane filtration method.
  2. Bacterial Endotoxins Test (BET): NMT 0.25 EU/mL, using kinetic turbidimetric LAL method (Annexure-2).
See also  Analytical Method Development: SOP for Osmolality Measurement in Sterile Products - V 2.0

5.4 Acceptance Criteria

  • All physicochemical and microbial parameters must meet USP/Ph. Eur./IP limits.
  • Failure in any parameter requires deviation investigation and retesting.

5.5 Method Validation Parameters

  1. Specificity: No interference in TOC and conductivity from sampling material or container.
  2. Precision: RSD ≤ 2% for replicate TOC and conductivity readings.
  3. Accuracy: TOC recovery within 85–115% of spiked standard.
  4. Limit of Detection: Below 100 ppb for TOC.

6. Abbreviations

  • WFI: Water for Injection
  • TOC: Total Organic Carbon
  • BET: Bacterial Endotoxins Test
  • EU: Endotoxin Units
  • CFU: Colony Forming Units

7. Documents

  1. WFI Test Record Sheet – Annexure-1
  2. Endotoxin Test Report – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • USP <1231>: Water for Pharmaceutical Purposes
  • Ph. Eur. 0169: Water for Injections
  • IP Monograph: Water for Injection
  • ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Priya Menon Sachin Deshmukh Sunita Reddy
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: WFI Test Record Sheet

Sample Location Conductivity (µS/cm) TOC (ppb) pH Status
Loop A – Point 1 1.1 212 5.8 Pass

Annexure-2: Endotoxin Test Report

Sample ID BET Method Result (EU/mL) Status
WFI-272-01 Kinetic Turbidimetric 0.05 Pass

Annexure-3: Validation Summary Report

The WFI quality testing procedure was validated as per USP <1231> and Ph. Eur. 0169. TOC analysis, conductivity, and endotoxin testing met all acceptance criteria. The method is robust, reproducible, and suitable for routine monitoring.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included TOC validation and BET updates Annual Review Sunita Reddy
10/04/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Titrimetric Assay Development for Alkalinity - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: How to Use Batch Record Reviews to Verify SOP Compliance
Next Post: Elixir Department: SOP for Odor Check During Final Blending – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version